Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Jane Qian
Introduction
Jane Qian is a notable inventor based in Libertyville, IL (US). She has made significant strides in the field of cancer treatment, particularly focusing on non-small cell lung cancer in smokers. Her work has the potential to impact many lives through innovative medical solutions.
Latest Patents
Jane Qian holds a patent for her invention titled "Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers." This invention pertains to a method for treating non-small cell lung cancer in subjects who are smokers. It involves administering an effective amount of 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (veliparib or ABT-888), or a pharmaceutically acceptable salt thereof, in combination with carboplatin and paclitaxel. She has 1 patent to her name.
Career Highlights
Jane Qian is currently associated with AbbVie Inc., a leading biopharmaceutical company. Her role at AbbVie allows her to contribute to groundbreaking research and development in the pharmaceutical industry. Her expertise and innovative mindset have positioned her as a valuable asset in her field.
Collaborations
Some of her notable coworkers include Vincent L. Giranda and Gary B. Gordon. Their collaborative efforts in research and development have further enhanced the impact of their work in cancer treatment.
Conclusion
Jane Qian's contributions to the field of cancer treatment exemplify the importance of innovation in medicine. Her patent and ongoing work at AbbVie Inc. highlight her commitment to improving patient outcomes.